Individual Differences in the Patient Experience of Relapsing Multiple Sclerosis (RMS): A Multi-Country Qualitative Exploration of Drivers of Treatment Preferences Among People Living with RMS-Reference-Cited by-同舟云学术

Individual Differences in the Patient Experience of Relapsing Multiple Sclerosis (RMS): A Multi-Country Qualitative Exploration of Drivers of Treatment Preferences Among People Living with RMS

Published:2023-04-05 Issue:4 Volume:16 Page:345-357
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Tatlock Sophi,Sully Kate,Batish Anjali^ORCID,Finbow Chelsea^ORCID,Neill William,Lines Carol,Brennan Roisin,Adlard Nicholas^ORCID,Backhouse Tamara^ORCID

Funder

Novartis Pharma

Publisher

Springer Science and Business Media LLC

Subject

General Engineering

Link

https://link.springer.com/content/pdf/10.1007/s40271-023-00617-y.pdf

Reference52 articles.

1. Olek MJ, Narayan RN, Frohman EM, Frohman TC (2018) Clinical features of multiple sclerosis in adults. UpToDate. UpToDate, Waltham, MA. Accessed 2 Apr 2018.

2. Stadelmann C, Wegner C, Brück W. Inflammation, demyelination, and degeneration—recent insights from MS pathology. Biochim Biophys Acta (BBA) Mol Basis Dis. 2011;1812(2):275–82.

3. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343(20):1430–8.

4. Bottomley C, Lloyd A, Bennett G, Adlard N. A discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in multiple sclerosis. J Med Econ. 2017;20(8):863–70.

5. Desborough J, Brunoro C, Parkinson A, et al. ‘It struck at the heart of who I thought I was’: a meta-synthesis of the qualitative literature examining the experiences of people with multiple sclerosis. Health Expect. 2020;23(5):1007–27.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing a Patient Preference Study on Subcutaneous Medical Devices: Incorporating Health Authority Scientific Advice and Patient Perspectives;2024-08-17

2. ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation;PharmacoEconomics - Open;2024-07-11

3. Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study;PLOS ONE;2024-02-07

4. Real-world treatment preferences among health care providers in the United States in selecting disease modifying therapies for patients with multiple sclerosis: a discrete choice experiment;Journal of Medical Economics;2023-11-23